![]() |
市场调查报告书
商品编码
1833649
手术手套市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测Surgical Gloves Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球手术手套市场价值为 8.811 亿美元,预计将以 12.4% 的复合年增长率成长,到 2034 年达到 29 亿美元。
已开发地区和新兴地区医疗保健支出的增加、外科手术的增多以及对现代医院基础设施的持续投资推动了市场扩张。感染预防意识的增强和对严格安全标准的遵守进一步刺激了需求。手套生产技术的进步,尤其是无粉和无乳胶替代品的采用,正在解决过敏问题,同时提高灵敏度、舒适度和耐用性。全球和地区卫生当局实施的监管框架确保符合严格的品质基准,增强了人们对使用外科手套的信任。亚太地区和拉丁美洲医疗保健可近性的扩大,加上全球对永续和环保材料的趋势,正在为製造商带来新的机会。这些发展共同凸显了安全、创新和不断发展的医疗保健服务体系如何塑造外科手套作为全球医疗实践重要组成部分的作用。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 8.811亿美元 |
预测值 | 29亿美元 |
复合年增长率 | 12.4% |
2024年,合成手套市场占了65.1%的份额,这得益于市场对无乳胶手套的需求,不仅能最大限度地降低过敏风险,还能提供耐化学性和耐用性。氯丁橡胶、丁腈橡胶和聚异戊二烯等合成材料因其卓越的防穿刺性能和耐用性,越来越多地应用于复杂、长时间的手术。
2024年,丁腈手套市场规模达到4.282亿美元,凭藉其在耐化学性、低致敏性以及对抗血源性病原体和细胞毒性药物方面的卓越表现,占据了主导地位。由于职业健康的考量,丁腈手套比乳胶手套更受青睐,在骨科和肿瘤科等高风险外科手术领域的应用日益广泛。
2024年,美国手术手套市场规模达2.527亿美元,这得益于先进的医疗基础设施、不断增长的手术需求以及日益转向丁腈和可持续手套的选择。成熟製造商积极投资于产品开发和创新,持续增强了美国国内市场前景。
影响全球手术手套市场的关键参与者包括 MEDLINE、TOP GLOVE、Semperit AG Holding、Ansell、SUPERMAX CORPORATION BERHAD、Hartalega、INTCO Medical、Cardinal Health、Kossan Rubber Industries 和 GLOBUS。为了巩固其在手术手套行业的地位,领先公司正在推行多种策略。研发投资旨在提高手套的性能、耐用性和舒适度,同时利用先进的合成材料解决过敏风险。企业也注重永续的生产实践,引入环保和可生物降解的方案,以实现全球环境目标。扩大新兴经济体的产能是另一个关键途径,可确保成本效益和更广泛的市场渗透。与医疗保健提供者和分销商的合作有助于企业确保稳定的需求并增强供应链的可靠性。
The Global Surgical Gloves Market was valued at USD 881.1 million in 2024 and is estimated to grow at a CAGR of 12.4% to reach USD 2.9 billion by 2034.
Market expansion is supported by increasing healthcare expenditure, rising surgical procedures, and continuous investments in modern hospital infrastructure across developed and emerging regions. Heightened awareness of infection prevention and adherence to strict safety standards are further stimulating demand. Technological progress in glove production, particularly the adoption of powder-free and latex-free alternatives, is addressing allergy concerns while improving sensitivity, comfort, and durability. Regulatory frameworks enforced by global and regional health authorities ensure compliance with strict quality benchmarks, driving trust in the adoption of surgical gloves. Expanding healthcare access in Asia-Pacific and Latin America, coupled with global trends toward sustainable and eco-conscious materials, is opening new opportunities for manufacturers. Together, these developments underscore how safety, innovation, and evolving healthcare delivery systems are shaping the role of surgical gloves as an essential part of medical practice worldwide.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $881.1 Million |
Forecast Value | $2.9 Billion |
CAGR | 12.4% |
The synthetic segment held a 65.1% share in 2024, supported by demand for latex-free gloves that minimize allergy risks while offering chemical resistance and durability. Synthetic options such as neoprene, nitrile, and polyisoprene are increasingly chosen for complex, long-duration surgeries due to their superior puncture protection and durability.
The nitrile gloves segment generated USD 428.2 million in 2024, establishing dominance with its strength in chemical resistance, hypoallergenic properties, and effectiveness against bloodborne pathogens and cytotoxic agents. Nitrile gloves are widely preferred over latex because of occupational health concerns, with growing use in high-risk surgical fields, including orthopedic and oncology procedures.
U.S. Surgical Gloves Market was valued at USD 252.7 million in 2024, driven by advanced medical infrastructure, rising surgical demand, and a growing shift toward nitrile and sustainable glove options. The presence of established manufacturers actively investing in product development and innovation continues to strengthen the domestic market outlook.
Key players shaping the Global Surgical Gloves Market include MEDLINE, TOP GLOVE, Semperit AG Holding, Ansell, SUPERMAX CORPORATION BERHAD, Hartalega, INTCO Medical, Cardinal Health, Kossan Rubber Industries, and GLOBUS. To reinforce their position in the surgical gloves industry, leading companies are pursuing multiple strategies. R&D investments are aimed at improving glove performance, durability, and comfort while addressing allergy risks with advanced synthetic materials. Firms are also focusing on sustainable production practices, introducing eco-friendly and biodegradable options to meet global environmental goals. Expanding manufacturing capacity in emerging economies is another key approach, ensuring cost efficiency and broader market penetration. Partnerships with healthcare providers and distributors help companies secure consistent demand and strengthen supply chain reliability.